1868 Federal Register / Vol. 79, No. 7 / Friday, January 10, 2014 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the National Vaccine 

Advisory Committee 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary for 

Health. 

ACTION: Notice of meeting. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that the National Vaccine Advisory 

Committee (NVAC) will hold a meeting. 

The meeting is open to the public. Preregistration is required for both public 

attendance and comment. Individuals 

who wish to attend the meeting and/or 

participate in the public comment 

session should register at http://

www.hhs.gov/nvpo/nvac, email nvpo@

hhs.gov, or call 202–690–5566 and 

provide name, organization, and email 

address. 

DATES: The meeting will be held on 

February 11–12, 2014. The meeting 

times and agenda will be posted on the 

NVAC Web site at http://www.hhs.gov/ 

nvpo/nvac as soon as they become 

available. 

ADDRESSES: U.S. Department of Health 

and Human Services, Hubert H. 

Humphrey Building, Room 800, 200 

Independence Avenue SW., 

Washington, DC 20201. 

FOR FURTHER INFORMATION CONTACT: 

National Vaccine Program Office, U.S. 

Department of Health and Human 

Services, Room 715–H, Hubert H. 

Humphrey Building, 200 Independence 

Avenue SW., Washington, DC 20201. 

Phone: (202) 690–5566; Fax: (202) 690– 

4631; email: nvpo@hhs.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to Section 2101 of the Public Health 

Service Act (42 U.S.C. 300aa–1), the 

Secretary of Health and Human Services 

was mandated to establish the National 

Vaccine Program to achieve optimal 

prevention of human infectious diseases 

through immunization and to achieve 

optimal prevention against adverse 

reactions to vaccines. The National 

Vaccine Advisory Committee was 

established to provide advice and make 

recommendations to the Director of the 

National Vaccine Program on matters 

related to the Program’s responsibilities. 

The Assistant Secretary for Health 

serves as Director of the National 

Vaccine Program. 

The topics to be discussed at the 

NVAC meeting will include 

presentations addressing the first annual 

report of progress on the National 

Vaccine Plan; adult immunizations, 

vaccine research, development, and 

innovation; vaccine financing, access to 

and supply of vaccines, and a report of 

the President’s Cancer Panel with a 

focus on HPV vaccination. In addition, 

NVAC working groups on Human 

Papillomavirus (HPV) Vaccine and 

Maternal Immunization will provide 

updates on the working groups’ 

progress. The meeting agenda will be 

posted on the NVAC Web site: http://

www.hhs.gov/nvpo/nvac prior to the 

meeting. 

Public attendance at the meeting is 

limited to space available. Individuals 

who plan to attend and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

National Vaccine Program Office at the 

address/phone listed above at least one 

week prior to the meeting. Members of 

the public will have the opportunity to 

provide comments at the NVAC meeting 

during the public comment periods on 

the agenda. Individuals who would like 

to submit written statements should 

email or fax their comments to the 

National Vaccine Program Office at least 

five business days prior to the meeting. 

Dated: January 6, 2014. 

Bruce Gellin, 

Director, National Vaccine Program Office, 

Executive Secretary, National Vaccine 

Advisory Committee. 

[FR Doc. 2014–00176 Filed 1–9–14; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

intention of the Agency for Healthcare 

Research and Quality (AHRQ) to request 

that the Office of Management and 

Budget (OMB) approve the proposed 

changes to the currently approved 

information collection project: ‘‘Medical 

Expenditure Panel Survey—Insurance 

Component.’’ In accordance with the 

Paperwork Reduction Act, 44 U.S.C. 

3501–3521, AHRQ invites the public to 

comment on this proposed information 

collection. 

DATES: Comments on this notice must be 

received by March 11, 2014. 

ADDRESSES: Written comments should 

be submitted to: Doris Lefkowitz, 

Reports Clearance Officer, AHRQ, by 

email at doris.lefkowitz@AHRQ.hhs.gov. 

Copies of the proposed collection 

plans, data collection instruments, and 

specific details on the estimated burden 

can be obtained from the AHRQ Reports 

Clearance Officer. 

FOR FURTHER INFORMATION CONTACT: 

Doris Lefkowitz, AHRQ Reports 

Clearance Officer, (301) 427–1477, or by 

email at doris.lefkowitz@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Proposed Project 

Medical Expenditure Panel Survey— 

Insurance Component 

Employer-sponsored health insurance 

is the source of coverage for 85 million 

current and former workers, plus many 

of their family members, and is a 

cornerstone of the U.S. health care 

system. The Medical Expenditure Panel 

Survey—Insurance Component (MEPS– 

IC) measures the extent, cost, and 

coverage of employer-sponsored health 

insurance on an annual basis. Statistics 

are produced at the National, State, and 

sub-State (metropolitan area) level for 

private industry. Statistics are also 

produced for State and Local 

governments. The MEPS–IC was last 

approved by OMB on November 21st, 

2013 and will expire on November 30th, 

2016. The OMB control number for the 

MEPS–IC is 0935–0110. All of the 

supporting documents for the current 

MEPS–IC can be downloaded from 

OMB’s Web site at http://

www.reginfo.gov/public/do/

PRAViewDocument?ref_nbr=201310- 

0935-001. 

In order to ensure that the MEPS–IC 

is able to capture important changes in 

the employer-sponsored health 

insurance market due to the 

implementation of the Patient 

Protection and Affordable Care Act 

(PPACA), AHRQ researched and 

proposed revisions to the 2014 survey 

questionnaires based on the law’s 

provisions. Many of these proposed 

revisions were related to the 

implementation of the Small Business 

Health Options Program (SHOP) 

exchanges/marketplaces that are 

available to small employers for 

purchasing health insurance beginning 

in 2014. 

The proposed revisions were sent to 

a variety of federal and private 

stakeholders to obtain their suggestions 

and comments. These stakeholders 

included the U.S. Department of Health 

and Human Services’ Assistant 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 79, No. 7 / Friday, January 10, 2014 / Notices 1869 

Secretary for Planning and Evaluation 

(ASPE), the Center for Medicare & 

Medicaid Services’ (CMS) Center for 

Consumer Information and Insurance 

Oversight, the CMS Office of the 

Actuary, the National Center for Health 

Statistics, the President’s Council of 

Economic Advisors, the Office of 

Management and Budget, the Bureau of 

Labor Statistics, the Employee Benefits 

Security Administration, the Bureau of 

the Census, and health insurance 

researchers at various universities and 

other not-for-profit organizations. These 

reviewers’ comments were invaluable, 

and are reflected in the questions 

proposed herein. 

In addition to the new questions 

recommended for 2014, several 

questions in the 2013 survey are 

proposed for deletion as part of the 2014 

improvements. These deletions are 

necessary to minimize the burden on 

survey respondents and are limited to 

those questions with less analytic value, 

with poor response rates, or those that 

are no longer relevant due to changes 

made under PPACA. 

Unlike for previous years’ additions to 

the MEPS–IC questionnaires, the Bureau 

of the Census—which conducts and 

processes the survey for AHRQ—was 

not able to pretest the proposed 2014 

questions. Many of the new questions 

relate to PPACA requirements or 

options (such as the SHOP 

marketplaces) which did not exist prior 

to the deadline for preparation of the 

2014 questionnaires, so employers 

would not yet have made changes to 

their health insurance coverage that 

could be researched to help in the 

development of the new questions. 

For all establishment-level MEPS–IC 

forms, AHRQ proposes to make the 

following changes. As noted below, 

some new questions only will be asked 

of private-sector establishments with 

certain firm sizes (defined by number of 

employees) or comparably-sized 

government units: 

Additions: 

< = 50 firm size only: 

• Did you offer health insurance 

through a small business (SHOP) 

exchange or marketplace in your State? 

Yes/No/Don’t Know 

All firm sizes, except very large 

businesses: 

• Last year, did your organization 

offer health insurance as a benefit to its 

employees at this location? Yes, offered 

in 2013/No, did not offer in 2013/Don’t 

Know 

All firm sizes: 

• How many employees reported in 

Question 2a above worked less than 30 

hours per week? 

ll employees 

Check box: No employees worked less 

than 30 hours 

• Are employees’ spouses eligible for 

health insurance coverage through your 

organization? 

All spouses are eligible/Only spouses 

not eligible through their own 

employer/No spouses eligible/Don’t 

Know 

Deletions: 

• Did your organization offer any 

health insurance as a benefit to its 

employees at this location between 

January 1, 2009 and December 31, 2013? 

Yes/No 

• What was the last year your 

organization offered health insurance 

coverage to its employees at this 

location? Last year offered 

• Did your organization offer health 

insurance to its temporary or seasonal 

employees at this location in 2014? Yes/ 

No/Organization has no temporary or 

seasonal employees/Don’t Know 

For all plan-level MEPS–IC forms, 

AHRQ proposes to make the following 

changes. As noted below, some new 

questions only will be asked of privatesector establishments with certain firm 

sizes or comparably-sized government 

units: 

Additions: 

< = 50 firm size only: 

• Health insurance plans are 

classified into different metal levels or 

tiers based on their level of benefits and 

cost-sharing provisions. Which level or 

tier was this plan in? Bronze/Silver/

Gold/Platinum/Don’t Know 

> 50 firm size only: 

• What is the actuarial value of this 

plan? 

The actuarial value is the percentage 

of medical expenses paid by the plan, 

rather than out-of-pocket by a covered 

person. 

ll % 

Check box: Do not know actuarial 

value 

All firm sizes: 

• You reported the total premium for 

a typical employee for SINGLE 

coverage. Did this premium vary for 

individual employees depending on 

their ages? Yes/No/Don’t Know 

• Did the amount individual 

employees contributed toward their 

single coverage vary by any of these 

characteristics? 

• Participation/achievement in 

fitness/weight loss program 

Æ Yes 

Æ No 

Æ Don’t Know 

• Participation/achievement in 

smoking cessation program 

Æ Yes 

Æ No 

Æ Don’t Know 

• Participation/achievement in 

wellness/health monitoring program 

Æ Yes 

Æ No 

Æ Don’t Know 

• Employee age 

Æ Yes: go to question below 

Æ No 

Æ Don’t Know 

• Other 

Æ Yes 

Æ No 

Æ Don’t Know 

• How did individual employees’ 

contributions vary by age? Employer 

pays same percent of premium, and 

premiums vary by age/Employer pays 

the same dollar amount toward 

premium, and premiums vary by age/

Other/Don’t Know 

• Did the total premium for FAMILY 

coverage vary depending on the number 

of family members covered by the plan? 

Yes/No/Don’t Know 

• How much and/or what percentage 

did an enrollee pay out-of-pocket for 

each type of prescription drug covered? 

• Generic 

Æ $ l Copay AND/OR l % 

Coinsurance 

• Preferred Brand Name 

Æ $ l Copay AND/OR l % 

Coinsurance 

• Non-preferred Brand Name 

Æ $ l Copay AND/OR l % 

Coinsurance 

Deletions: 

• Did the PREMIUMS for this 

insurance plan vary by any of these 

characteristics? 

Age/Gender/Wage or salary levels/

Smoker/Non-smoker status/Other 

• Did the amount an EMPLOYEE 

CONTRIBUTED toward his/her own 

coverage vary by any of these employee 

characteristics? Hours worked/Union 

status/Wage or salary levels/

Occupation/Length of employment/

Participation in a fitness/Weight loss 

program/Participation in a smoking 

cessation program/Other 

• How much and/or what percentage 

did an enrollee pay out-of-pocket for the 

lowest tier of prescription drug 

coverage? $ copayment/% coinsurance 

• Could this plan have refused to 

cover persons with pre-existing medical 

or health conditions? 

Yes/No 

• Did this plan have a policy 

requiring a waiting period before 

covering pre-existing conditions? 

Yes/No 

mstockstill on DSK4VPTVN1PROD with NOTICES

1870 Federal Register / Vol. 79, No. 7 / Friday, January 10, 2014 / Notices 

The MEPS Definitions form—MEPS– 

20(D)—will also be updated with new 

definitions for terms used in these new 

questions (and the deletion of terms 

used only in the deleted questions). 

There are no changes to the 2014 

MEPS–IC survey estimates of cost and 

hour burdens due to these proposed 

question changes. The response rate for 

the MEPS–IC survey also is not 

expected to change due to these 

proposed changes. 

The MEPS–IC is conducted pursuant 

to AHRQ’s statutory authority to 

conduct surveys to collect data on the 

cost, use and quality of health care, 

including the types and costs of private 

health insurance. 42 U.S.C. 299b–2(a). 

Method of Collection 

There are no changes to the current 

data collection methods. 

Estimated Annual Respondent Burden 

There are no changes to the current 

burden estimates. 

Estimated Annual Costs to the Federal 

Government 

There are no changes to the current 

cost estimates. 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 

information collection are requested 

with regard to any of the following: (a) 

whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ healthcare 

research and healthcare information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: December 23, 2013. 

Richard Kronick, 

Director. 

[FR Doc. 2013–31480 Filed 1–9–14; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2012–0013] 

Notice of Availability of the Draft 

Environmental Impact Statement and 

Public Hearing 

AGENCY: Centers for Disease Control and 

Prevention, HHS. 

ACTION: Notice of Availability. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), within 

the Department of Health and Human 

Services (HHS), announces the 

availability of the Roybal Campus 2025 

Master Plan Draft Environmental Impact 

Statement (DEIS) for public review and 

comment. This notice also announces 

the date, location and time for the 

public hearing. The DEIS analyzes the 

potential impacts associated with the 

implementation of the 2015–2025 

Master Plan (Master Plan) for HHS/

CDC’s Edward R. Roybal Campus 

(Roybal Campus) located at 1600 Clifton 

Road NE., in Atlanta, Georgia. This 

announcement follows the requirements 

of the National Environmental Policy 

Act of 1969 (NEPA) as implemented by 

the Council on Environmental Quality 

(CEQ) Regulations (40 CFR Part 1500– 

1508); and, the Department of Health 

and Human Services (HHS) General 

Administration Manual Part 30 

Environmental Procedures, dated 

February 25, 2000. 

DATES: A public meeting will be held on 

Wednesday, January 29, 2014 at the 

CDC Edward R. Roybal Campus, 1600 

Clifton Road NE. in Atlanta, Georgia 

beginning with an ‘‘open house’’ at 6:00 

p.m. EST. A formal presentation, 

followed by a public comment period 

will follow at approximately 7:00 p.m. 

EST. Written comments must be 

received on or before Monday, March 3, 

2014. 

Deadline for Requests for Special 

Accommodations: Persons wishing to 

participate in the public meeting who 

need special accommodations should 

contact George Chandler (gec2@cdc.gov 

or (404) 639–5153) by Wednesday, 

January 22, 2014. 

ADDRESSES: Requests for information on 

the DEIS or for a paper/electronic copy 

should be directed to: George F. 

Chandler, Senior Advisor, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE., Mailstop A–22, 

Atlanta, Georgia 30333. Information 

may also be requested on the DEIS by 

electronic mail at gec2@cdc.gov or by 

telephone at (404) 639–5153. The DEIS 

will be available on the Federal 

eRulemaking Portal: http://

www.regulations.gov, identified by 

Docket No. CDC–2012–0013. Hard 

copies of the DEIS are also available for 

review at locations listed in the 

Availability of the DEIS under 

SUPPLEMENTARY INFORMATION. 

You may submit comments identified 

by Docket No. CDC–2012–0013, by any 

of the following methods: 

Federal eRulemaking Portal: http://

www.regulations.gov. Follow the 

instructions for submitting comments. 

Mail: George F. Chandler, Senior 

Advisor, Centers for Disease Control and 

Prevention, 1600 Clifton Road NE., 

Mailstop A–22, Atlanta, Georgia 30333 

Instructions: All submissions received 

must include the agency name and 

Docket Number. All relevant comments 

received will be posted without change 

to http://www.regulations.gov, including 

any personal information provided. For 

access to the docket, to read background 

documents or comments received, go to 

http://www.regulations.gov. 

Written and verbal comments on the 

DEIS will also be accepted during the 

public meeting scheduled for 

Wednesday, January 29, 2014, at the 

CDC Edward R. Roybal Campus, Tom 

Harkin Global Communications Center 

(Building 19), Auditorium A, 1600 

Clifton Road NE., Atlanta, GA 30333. 

Please be advised that the meeting is 

being held in a Federal government 

building; therefore, Federal security 

measures are applicable. For additional 

information please see Roybal Campus 

Security Guidelines under 

SUPPLEMENTARY INFORMATION. 

FOR FURTHER INFORMATION CONTACT: 

George F. Chandler, Senior Advisor, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE., 

Mailstop A–22, Atlanta, Georgia 30333. 

Telephone: (404) 639–5153. 

SUPPLEMENTARY INFORMATION: HHS/CDC 

has prepared a new long-range Master 

Plan to guide the future physical 

development of the Roybal Campus for 

the planning horizon of 2015 to 2025. 

The previous 2000–2009 Master Plan 

has been implemented, and as a result, 

a new plan is needed in order to ensure 

that the campus can support HHS/CDC’s 

mission and program requirements 

through 2025. Mission change and 

growth resulting from emerging or 

reemerging infectious diseases, 

reclassification of pathogens and 

potential Program staff growth over time 

are expected to drive increases in 

laboratory and non-laboratory staff and 

demand for specialized space. The 

Master Plan provides an update of 

mstockstill on DSK4VPTVN1PROD with NOTICES